Drugs & Targets Estonia to develop personalized CAR T-cell therapy for blood cancer patients May 31, 2024Vol.50 No.22
Drugs & Targets Secarna, Orbit collaborate to develop peptide-conjugated targeted ASO therapeutics May 31, 2024Vol.50 No.22
Drugs & Targets Cartography, Gilead collaborate to develop therapies for breast and lung cancers May 31, 2024Vol.50 No.22
Obituary Richard Simon, NCI’s visionary biostatistician, dies at 80 May 24, 2024Vol.50 No.21By Paul Goldberg
Capitol Hill As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25 May 24, 2024Vol.50 No.21By McKenzie Prillaman
NCI: Cancer center communicators are key to the success of the National Cancer Plan May 24, 2024Vol.50 No.21By Jacquelyn Cobb
Trials & Tribulations Are we focused on the wrong risk type in genetic screening?Breast cancer screening study shows new paths to population screening May 24, 2024Vol.50 No.21By Cassie Hajek
Guest Editorial Training programs for medical educators can overcome barriers in global oncologyHow an education program in Ethiopia increased access to cancer pain management May 24, 2024Vol.50 No.21By Ethan Dmitrovsky
In Brief Jonathan Yang named director of clinical research at NYU Brain and Spine Tumor Center May 24, 2024Vol.50 No.21
In Brief Sajeel Chowdhary named medical director of neuro-oncology at Tampa General May 24, 2024Vol.50 No.21
